The chemicals producer now has a total of more than $280m under management for its corporate venturing activities, having launched its first fund six years ago.

Germany-based chemicals producer Evonik launched its second corporate venture capital fund today with a €150m ($170m) commitment, increasing its funds under management to €250m. Evonik formed its Evonik Venture Capital unit in 2012, providing an initial €100m, and corporate has since built up a 25-strong portfolio of direct and fund-of-fund investments. Those portfolio companies include…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.